Apollo Hospitals Enterprise Limited

rs,

5 06t11 November 2025 The Secretary, Bombay Stock Exchange Ltd (BSE) Phiroze Jheejheebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code - 508869 ISIN INE437A01024 Dear Sir, 'G' Block T

9%

Revenue Growth YoY(%) EBITDA(Post Ind AS) Margin Growth YoY(%) Healthcare Services 31,690 9% 7,810 24.6% 8% PAT 4,101 Growth YoY(%) 12.9% 13% Offline PD ^ 23,347 16% 1,812 7.

24.6%

wth YoY(%) EBITDA(Post Ind AS) Margin Growth YoY(%) Healthcare Services 31,690 9% 7,810 24.6% 8% PAT 4,101 Growth YoY(%) 12.9% 13% Offline PD ^ 23,347 16% 1,812 7.8% 19% Online

8%

Y(%) EBITDA(Post Ind AS) Margin Growth YoY(%) Healthcare Services 31,690 9% 7,810 24.6% 8% PAT 4,101 Growth YoY(%) 12.9% 13% Offline PD ^ 23,347 16% 1,812 7.8% 19% Online PD^

12.9%

Growth YoY(%) Healthcare Services 31,690 9% 7,810 24.6% 8% PAT 4,101 Growth YoY(%) 12.9% 13% Offline PD ^ 23,347 16% 1,812 7.8% 19% Online PD^ & 24|7 3,259 22% (710) Vs (1

13%

h YoY(%) Healthcare Services 31,690 9% 7,810 24.6% 8% PAT 4,101 Growth YoY(%) 12.9% 13% Offline PD ^ 23,347 16% 1,812 7.8% 19% Online PD^ & 24|7 3,259 22% (710) Vs (1,006)

16%

es 31,690 9% 7,810 24.6% 8% PAT 4,101 Growth YoY(%) 12.9% 13% Offline PD ^ 23,347 16% 1,812 7.8% 19% Online PD^ & 24|7 3,259 22% (710) Vs (1,006) in Q2FY25 o C h t l a e H

7.8%

9% 7,810 24.6% 8% PAT 4,101 Growth YoY(%) 12.9% 13% Offline PD ^ 23,347 16% 1,812 7.8% 19% Online PD^ & 24|7 3,259 22% (710) Vs (1,006) in Q2FY25 o C h t l a e H o l l o p A

19%

810 24.6% 8% PAT 4,101 Growth YoY(%) 12.9% 13% Offline PD ^ 23,347 16% 1,812 7.8% 19% Online PD^ & 24|7 3,259 22% (710) Vs (1,006) in Q2FY25 o C h t l a e H o l l o p A Tota

22%

th YoY(%) 12.9% 13% Offline PD ^ 23,347 16% 1,812 7.8% 19% Online PD^ & 24|7 3,259 22% (710) Vs (1,006) in Q2FY25 o C h t l a e H o l l o p A Total HealthCo 26,606 17% 1,102

17%

3,259 22% (710) Vs (1,006) in Q2FY25 o C h t l a e H o l l o p A Total HealthCo 26,606 17% 1,102 4.1% 731 2.7% 284% AHLL 4,739 17% 500 10.6% 21% (60) Consolidated 63,035

4.1%

(710) Vs (1,006) in Q2FY25 o C h t l a e H o l l o p A Total HealthCo 26,606 17% 1,102 4.1% 731 2.7% 284% AHLL 4,739 17% 500 10.6% 21% (60) Consolidated 63,035 13% 9,412 1

“Chennai Tel Telefax Email Website : 044 - 28290956 / 3896 / 6681 : 044 - 2829 0956 : investor.relations@apollohospitals.com : www.apollohospitals.com Apollo Hospitals Enterprise Limited Earnings Update Q2 FY26 • Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference.”

“You acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the business of the Company.”

“• Private and Generic Label sales at 16.5% (offline) for Q2 FY26.”

“in Q2FY26, growth of 16% over Q2 FY25 Full stack digital healthcare platform • First-in-class AI enabled technologies including India’s first Clinical Intelligence Engine • Provides comprehensive remote healthcare services.”

“in H2 il)A e Apollo Soectra Specialists IHOSPITALS in Surgery ~lo Cradle &Children's Hospital ltollo Fertility  Sector witnessing strong competitive headwinds  Spectra: Revenue growth in H1 FY26 primarily driven by renovated Centres of Jaipur & Delhi  Cradle: ~7% YoY revenue growth in H1 FY26.”

“ Fertility: ~6% YoY revenue growth in H1 FY26.”

“gross realization per patient (INR)* Network Growth – Collection Centers # Operational footprint (as of Sep 30, 2025) ~340+ ~330+ ~330+ Cities Cities presence Cities presence presence 111 Labs 827 806 811 822 13,697 16,205 14,420 14,898 2,330 -19 717 20,820 733 24,535 2,221 2,215 2,102 2,108 2,311 2,300+ Collection Centres Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Footfalls / Day** Gross ARPV (Rs.) 1.”

“190 Mn) o Lowest cash loss of Rs 386 Mn in Q2’FY26”

“• Omnichannel Pharmacy (AHL+ APL) : Revenue of Rs 34,292 Mn in Q2’ FY26 compared to Rs.”

“o Platform GMV : Rs 7,230 Mn in Q2’ FY26, growth of 16% over Q2’ FY25 (6,212 Mn) o Consistent source for new customer acquisition (launch of 19 mins & Omni Acquisition).”

Omnichannel Healthcare Division

2

Digital Operational Metrics

2

Regd. Office

1

General Office

1

General Office

"Ali Towers" Ill Floor, #55, Greams Road, - 600 006. Chennai Tel Telefax Email Website : 044 - 28290956 / 3896 / 6681 : 044 - 2829 0956 : investor.relations@apollohospitals.com : www.apollohospitals.com Apollo Hospitals Enterprise Limited Earnings Update Q2 FY26 • Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor any part thereof may be (i) used or relied upon by any other party or for any other purpose; (ii) copied, photocopied, duplicated or otherwise reproduced in any form or by any means; or (iii) redistributed, passed on or otherwise disseminated, to any other person without the prior written consent of the Company. Although care has been taken to ensure that the information in this presentation is accurate, and that the opinions express

Omnichannel Healthcare Division

• Omnichannel Pharmacy (AHL+ APL) : Revenue of Rs 34,292 Mn in Q2’ FY26 compared to Rs. 28,768 Mn in Q2’ FY25 (growth of 19%). • Serving ~1 Mn transactions every day

Digital Operational Metrics

o Platform GMV : Rs 7,230 Mn in Q2’ FY26, growth of 16% over Q2’ FY25 (6,212 Mn) o Consistent source for new customer acquisition (launch of 19 mins & Omni Acquisition). o Continuous Improvement in quantitative parameters in Q2’ FY26 vs Q2’ FY25: o 30% YoY growth in Online Pharma Transactions o 30% YoY growth in Transacting users Offline Segment o 12% YoY growth in offline transactions (8.7 cr Vs 7.8 cr year back). 31 ` MioOffline Pharmacy Distribution Online Pharmacy Distribution & Apollo 247Total HealthCoTotal Revenues23,3473,25926,606EBITDA (Pre 24|7 Cost)#1,8125482,361margin (%) 7.8%16.8%8.9%24/7 Operating Cost-935-935ESOP(Non Cash expense)-324-324EBITDA 1,812-7101,102margin (%) 7.8%-4.1%EBIT860PBT735PAT (Reported)734Total Revenues20,1442,67822,822EBITDA (Pre 24|7 Cost)#1,5273461,874margin (%) 7.6%12.9%8.2%24/7 Operating Cost-1,197-1,197ESOP(Non Cash expense)-156-156EBITDA 1,527-1,006521margin (%) 7.6%-2.3%EBIT389PBT190PAT (Reported)190Revenue16%22%17%EBITDA (Pre 24|7 Cost)19%58%26

Omnichannel Healthcare Division

o Omnichannel Pharmacy (AHL+ APL) : Revenue of Rs 65,933 Mn in H1’ FY26 compared to Rs. 54,916 Mn in H1’ FY25 (growth of 20%). o Apollo Telehealth (under AHEL) – Generated Revenue of Rs 326 Mn, with a positive EBITDA of Rs 6 mn in H1 FY26. o Serving ~1 Mn transactions every day

Digital Operational Metrics

o Platform GMV : Rs 14,050 Mn in H1’ FY26, growth of 20% over H1’ FY25 (11,745 Mn) o Consistent source for new customer acquisition (launch of 19 mins & Omni Acquisition). New Lob- Insurance started gaining attraction o Continuous Improvement in quantitative parameters in Q2’ FY26 vs Q2’ FY25: o 36% YoY growth in Online Pharma Transactions o 33% YoY growth in Transacting users Offline Segment # Excluding 24|7 operating Cost and ESOP Non-Cash Charge Digital Cash loss* (in Mn) H1'FY25 -1,817 52% H1'FY26 -874 *Cash loss/profit is EBITDA post Ind As excluding ESOP expense © 2025 Apollo Hospitals Enterprise Ltd, All Rights Reserved Healthco Cash profit* (in Mn) 137% 2,608 1,098 H1'FY25 H1'FY26 o 13% YoY growth in offline transactions (16.7 cr Vs 14.8 cr year back). 32 ` MioOffline Pharmacy Distribution Online Pharmacy Distribution & Apollo 247Total HealthCoTotal Revenues44,9816,34351,324EBITDA (Pre 24|7 Cost)#3,4811,0244,506margin (%) 7.7%16.1%8.8%24/7 Operating Cost-1,898-1,898ESOP(Non Cas